CareLit · DOI-Nachweis · Nervenheilkunde
Genetic Replacement Therapy (GRT) Clinical Trial with AVXS-101 in Presymptomatic Spinal Muscular Atrophy (SMA): Design of the Phase III Trial and Baseline Demographic Data
DOI 10.1055/s-0039-1685081
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Schultz, K Swoboda, E Kernbauer, F Ogrinc, DE Feltner, BE McGill, DM Sproule, KA Strauss
ZeitschriftNervenheilkunde
Ausgabe05/2019
Jahrgang / SeitenJg. 38
Kernaussage aus der Literatur
Abstract-Vorschau
Genetic Replacement Therapy (GRT) Clinical Trial with AVXS-101 in Presymptomatic Spinal Muscular Atrophy (SMA): Design of the Phase III Trial and Baseline Demographic Data
Zitieren
Zitierempfehlung
M Schultz, K Swoboda, E Kernbauer, F Ogrinc, DE Feltner, BE McGill, DM Sproule, KA Strauss (2019) Genetic Replacement Therapy (GRT) Clinical Trial with AVXS-101 in Presymptomatic Spinal Muscular Atrophy (SMA): Design of the Phase III Trial and Baseline Demographic Data. Nervenheilkunde, 38 (05). https://doi.org/10.1055/s-0039-1685081
Mit CareLit weiterarbeiten